Session 4: Special situation I: Signet Ring Cell Cancer

Chairs: Eric Van Cutsem (Belgium), Radka Obermannova (Czech Republic)

  • Heike Grabsch, The Netherlands: Signet ring cell carcinoma in the stomach: histopathological definitions and response to therapy assessment – the urgent need for an international consensus 
  • Stefan Seewald, Switzerland: Endoscopic approach to signet ring cell cancer 
  • Antoine Adenis, France: Is there a role for neoadjuvant or adjuvant chemotherapy or radiochemotherapy in signet ring cell cancer?

permission for all webcast uploads except discussion pending